1. Home
  2. MMS vs RGC Comparison

MMS vs RGC Comparison

Compare MMS & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maximus Inc.

MMS

Maximus Inc.

N/A

Current Price

$64.61

Market Cap

3.2B

ML Signal

N/A

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

N/A

Current Price

$4.92

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMS
RGC
Founded
1975
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MMS
RGC
Price
$64.61
$4.92
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $92.50
N/A
AVG Volume (30 Days)
★ 524.2K
296.0K
Earning Date
11-19-2026
11-24-2026
Dividend Yield
★ 2.04%
N/A
EPS Growth
★ 10.42
N/A
EPS
★ 5.45
N/A
Revenue
★ $2,392,236,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$11.86
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$51.04
$4.51
52 Week High
$100.00
$69.00

Technical Indicators

Market Signals
Indicator
MMS
RGC
Relative Strength Index (RSI) 55.95 34.17
Support Level $56.57 $4.71
Resistance Level $70.65 $6.40
Average True Range (ATR) 2.22 0.60
MACD -0.30 -0.24
Stochastic Oscillator 36.57 5.66

Price Performance

Historical Comparison
MMS
RGC

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: